Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

Celularity (CELUW) Gains from Investment Securities (2020 - 2025)

Historic Gains from Investment Securities for Celularity (CELUW) over the last 6 years, with Q3 2025 value amounting to $4.3 million.

  • Celularity's Gains from Investment Securities rose 69719.89% to $4.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $4.6 million, marking a year-over-year increase of 29584.78%. This contributed to the annual value of $434000.0 for FY2024, which is 10041.6% up from last year.
  • According to the latest figures from Q3 2025, Celularity's Gains from Investment Securities is $4.3 million, which was up 69719.89% from $1.3 million recorded in Q2 2025.
  • In the past 5 years, Celularity's Gains from Investment Securities registered a high of $36.5 million during Q1 2021, and its lowest value of -$52.8 million during Q4 2022.
  • Moreover, its 5-year median value for Gains from Investment Securities was -$718000.0 (2024), whereas its average is -$7.1 million.
  • Data for Celularity's Gains from Investment Securities shows a peak YoY increase of 839170.72% (in 2021) and a maximum YoY decrease of 6656418.59% (in 2021) over the last 5 years.
  • Quarter analysis of 5 years shows Celularity's Gains from Investment Securities stood at -$23.3 million in 2021, then crashed by 126.76% to -$52.8 million in 2022, then skyrocketed by 90.18% to -$5.2 million in 2023, then surged by 86.08% to -$722000.0 in 2024, then soared by 690.58% to $4.3 million in 2025.
  • Its last three reported values are $4.3 million in Q3 2025, $1.3 million for Q2 2025, and -$242000.0 during Q1 2025.